Interaction between factor XIIi and serine proteases
Sakuragawa, N.
Nihon Ketsueki Gakkai Zasshi Journal of Japan Haematological Society 40(6): 1008-1014
1977
ISSN/ISBN: 0001-5806 PMID: 610318 Document Number: 124080
Document emailed within 1 workday
Related Documents
Lapan, K.A.; Fay, P.J. 1998: Interaction of the A1 subunit of factor VIIIa and the serine protease domain of factor X identified by zero-length cross-linking Thrombosis and Haemostasis 80(3): 418-422Cercek, L.; Cercek, B. 1993: Cancer-associated SCM-recognition, immunedefense suppression, and serine protease protection peptide. Part III. CRISPP peptide protection of serine proteases against inhibition Cancer Detection and Prevention 17(3): 447-454
Gál, Péter.; Dobó, József.; Beinrohr, László.; Pál, Gábor.; Závodszky, Péter. 2013: Inhibition of the serine proteases of the complement system Advances in Experimental Medicine and Biology 735: 23-40
Kawagoe, H. 1976: A case of congenital factor XIIi deficiency and acquired factor XIIi deficiency Rinsho Byori. Japanese Journal of Clinical Pathology 24(4): 286
Mitoma, J.; Furuya, S.; Hirabayashi, Y. 1999: A novel metabolic interaction between neurons and glial cells through L-serine: an essential role for astroglia-derived L-serine in the survival and development of CNS neurons Seikagaku. Journal of Japanese Biochemical Society 71(7): 536-541
Ewoldt, G.R.; Smyth, M.J.; Darcy, P.K.; Harris, J.L.; Craik, C.S.; Horowitz, B.; Woodard, S.L.; Powers, J.C.; Hudig, D. 1997: P-4 and RNKP-7, new granzyme-like serine proteases expressed in activated rat lymphocytes Journal of Immunology 158(10): 4574-4583
Rauterberg, E.W.; Ritz, E. 1988: Bioincompatibility of dialysis membranes: factor H binding correlates inversely with complement activation indicating a local imbalance of involved proteases/anti-proteases Advances in Experimental Medicine and Biology 240: 365-375
Bokarewa, M.I.; Hellstrand, K.; Tarkowski, A. 2002: Phosphorotioated oligonucleotides trigger synthesis of human coagulation serine proteases Thrombosis and Haemostasis 88(5): 788-793
Olson, M.O.; Nagabhushan, N.; Dzwiniel, M.; Smillie, L.B.; Whitaker, D.R. 1970: Primary structure of alpha-lytic protease: a bacterial homologue of the pancreatic serine proteases Nature 228(5270): 438-442
Niles, R.M.; Christensen, T.G.; Breuer, R.; Stone, P.J.; Snider, G.L. 1986: Serine proteases stimulate mucous glycoprotein release from hamster tracheal ring organ culture Journal of Laboratory and Clinical Medicine 108(5): 489-497
Hudig, D.; Allison, N.J.; Pickett, T.M.; Winkler, U.; Kam, C.M.; Powers, J.C. 1991: The function of lymphocyte proteases. Inhibition and restoration of granule-mediated lysis with isocoumarin serine protease inhibitors Journal of Immunology 147(4): 1360-1368
Vilain, A.C.; Pirotte, B.; Vergely, I.; Boggetto, N.; Masereel, B.; Schynts, M.; Delarge, J.; Reboud-Ravaux, M. 1993: Evaluation of the inhibitory activity on serine and aspartic proteases of 4-amino-4H-1,2,4-triazole and 5-aminothiazole derivatives structurally related to beta-lactam antibiotics Journal of Pharmacy and Pharmacology 45(5): 466-472
Kloczko, J.; Zuch, A.; Bielawiec, M.; Buluk, K. 1980: Factor XIIi (FSF - fibrin stabilizing factor) in pathological states with thrombin generation Haematologica 65(5): 629-635
Rossi, A.; Argenziano, G. 1970: Factor XIIi (fibrin stabilizing factor) in various dermatological diseases (screening test) Archives d'Anatomie Microscopique et de Morphologie Experimentale 59(2): 198-201
Kłoczko, J.; Zuch, A.; Bielawiec, M.; Buluk, K. 1983: Activity of fibrin stabilizing factor (FSF; factor XIII) in lymphoproliferative disorders Acta Haematologica Polonica 14(1): 13-19
Egbring, R.; Schmidt, W.; Havemann, K. 1973: Etiology of factor XIII, factor V and fibrinogen deficiency in acute leukemias Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1351-1354
Brandt, M.; Hofmann, K.D.; Wagner, F.; Koob, P. 1978: Effect of hormonal contraception on the fibrin-stabilizing factor (factor XIII) Zentralblatt für Gynakologie 100(17): 1089-1092
Hung, I.J. 1980: Congenital deficiency of fibrin-stabilizing factor (factor XIII) Journal of the Formosan Medical Association 79(11): 1025-1031
España, F.; Ratnoff, O.D. 1983: Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases Journal of Laboratory and Clinical Medicine 102(1): 31-45
Zuch, A.; Rudobielska, M.; Zwierzowa, W.; Jurgielewicz, E.; Buluk, K. 1972: Ontogenetic variability of fibrin stabilizing factor level (FSF--Factor XIII of blood coagulation system) in the plasma of healthy children Pediatria Polska 47(10): 1197-1203